Total Payments
$5,653
2024 Payments
$1,667
Companies
22
Transactions
304
Medicare Patients
1,792
Medicare Billing
$113,101
Payment Breakdown by Category
Food & Beverage$5,108 (90.4%)
Education$544.96 (9.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,108 | 296 | 90.4% |
| Education | $544.96 | 8 | 9.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,586 | 87 | $0 (2024) |
| ABBVIE INC. | $890.24 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $525.16 | 47 | $0 (2024) |
| Amgen Inc. | $479.01 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $355.01 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $345.77 | 11 | $0 (2024) |
| GENZYME CORPORATION | $328.44 | 15 | $0 (2024) |
| Incyte Corporation | $228.30 | 11 | $0 (2023) |
| UCB, Inc. | $226.40 | 10 | $0 (2024) |
| PFIZER INC. | $112.57 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,667 | 85 | Janssen Biotech, Inc. ($434.36) |
| 2023 | $2,295 | 113 | Janssen Biotech, Inc. ($744.04) |
| 2022 | $1,005 | 57 | Janssen Biotech, Inc. ($222.25) |
| 2021 | $685.75 | 49 | Janssen Biotech, Inc. ($185.72) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $106.71 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.20 | General |
| Category: Immunology | ||||||
| 11/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Immunology | ||||||
| 10/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Teva Pharmaceuticals USA, Inc. | SIMLANDI (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 977 | 1,606 | $309,469 | $75,960 |
| 2021 | 11 | 608 | 1,033 | $146,479 | $31,929 |
| 2020 | 7 | 207 | 379 | $43,074 | $5,212 |
Total Patients
1,792
Total Services
3,018
Medicare Billing
$113,101
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 24 | 50 | $48,891 | $14,469 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 164 | $52,944 | $13,033 | 24.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 114 | 134 | $39,363 | $9,985 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 168 | $38,368 | $9,306 | 24.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 197 | 219 | $37,745 | $7,272 | 19.3% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 24 | 37 | $27,030 | $6,651 | 24.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 48 | 52 | $13,652 | $3,009 | 22.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 138 | 653 | $11,316 | $2,897 | 25.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 26 | 26 | $11,302 | $2,541 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $10,182 | $2,273 | 22.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 20 | 22 | $7,527 | $1,732 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $7,133 | $1,726 | 24.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 28 | $4,017 | $1,067 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 103 | $33,676 | $6,957 | 20.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 136 | 141 | $23,801 | $4,372 | 18.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 82 | $18,897 | $4,151 | 22.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 53 | 54 | $15,783 | $3,681 | 23.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $11,821 | $2,728 | 23.1% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 21 | 21 | $8,910 | $2,329 | 26.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 107 | 507 | $8,492 | $2,088 | 24.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 33 | 34 | $9,105 | $1,999 | 22.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $9,335 | $1,935 | 20.7% |
| 17111 | Destruction of 15 or more non-cancerous skin growths | Office | 2021 | 11 | 12 | $4,100 | $1,030 | 25.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 18 | $2,559 | $657.22 | 25.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 44 | $11,352 | $1,149 | 10.1% |
About Mary Burnell, PA-C
Mary Burnell, PA-C is a Physician Assistant healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/07/2015. The National Provider Identifier (NPI) number assigned to this provider is 1124416508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Burnell, PA-C has received a total of $5,653 in payments from pharmaceutical and medical device companies, with $1,667 received in 2024. These payments were reported across 304 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,108).
As a Medicare-enrolled provider, Burnell has provided services to 1,792 Medicare beneficiaries, totaling 3,018 services with total Medicare billing of $113,101. Data is available for 3 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Portland, OR
- Active Since 01/07/2015
- Last Updated 10/26/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1124416508
Products in Payments
- TREMFYA (Drug) $1,124
- SKYRIZI (Biological) $669.32
- DUPIXENT (Biological) $650.71
- Otezla (Drug) $479.01
- REMICADE (Biological) $462.34
- Sotyktu (Drug) $355.01
- COSENTYX (Drug) $346.66
- OPZELURA (Drug) $228.30
- Bimzelx (Biological) $180.93
- COSENTYX (Biological) $178.50
- RINVOQ (Biological) $116.15
- VTAMA (Drug) $82.15
- EUCRISA (Drug) $76.19
- HUMIRA (Biological) $63.94
- IDACIO (Biological) $57.08
- Cimzia (Drug) $45.47
- ARAZLO (Drug) $39.98
- JUBLIA (Drug) $39.81
- CIBINQO (Drug) $36.38
- TALTZ (Drug) $29.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Portland
Ryan Cain, Pa-C, PA-C
Physician Assistant — Payments: $54,550
Physician Assistant $54,550
Sean Brown, Pa-C, PA-C
Physician Assistant — Payments: $37,064
Physician Assistant $37,064
Skye Peltier, Pa, PA
Physician Assistant — Payments: $25,055
Physician Assistant $25,055
Elizabeth Bailey, Pa, PA
Physician Assistant — Payments: $23,027
Physician Assistant $23,027
Meegan Mangum, Pa-C, PA-C
Physician Assistant — Payments: $10,828
Physician Assistant $10,828
Thomas Sexton, Pa-C, PA-C
Physician Assistant — Payments: $8,800
Physician Assistant $8,800